InnovAge Holding Corp. (INNV)
USD 3.75
(-8.09%)
USD 3.75
(-8.09%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 1.15 Million USD | 103.95% |
| 2023 | -29.24 Million USD | -467.44% |
| 2022 | 9.21 Million USD | 7.24% |
| 2021 | -5.88 Million USD | -86.04% |
| 2020 | 61.54 Million USD | 30.6% |
| 2019 | 45.91 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - USD | 103.41% |
| 2024 Q2 | 1.49 Million USD | 131.83% |
| 2024 Q4 | 5.78 Million USD | 1886.11% |
| 2024 Q1 | -5.8 Million USD | 18.38% |
| 2024 Q3 | 437 Thousand USD | -121.64% |
| 2023 Q3 | -4.27 Million USD | 55.32% |
| 2023 FY | - USD | -467.44% |
| 2023 Q4 | -6.86 Million USD | -60.5% |
| 2023 Q2 | -9.57 Million USD | 27.1% |
| 2023 Q1 | -13.13 Million USD | -49.15% |
| 2022 Q3 | -2.71 Million USD | -143.28% |
| 2022 Q4 | -8.8 Million USD | -224.31% |
| 2022 Q1 | 14.46 Million USD | 5.55% |
| 2022 Q2 | 6.27 Million USD | -56.62% |
| 2022 FY | - USD | 7.24% |
| 2021 Q4 | 13.7 Million USD | 109.19% |
| 2021 FY | - USD | -86.04% |
| 2021 Q2 | 23.64 Million USD | 167.0% |
| 2021 Q3 | 6.54 Million USD | -72.3% |
| 2021 Q1 | -35.28 Million USD | -252.04% |
| 2020 Q3 | 15.98 Million USD | 0.0% |
| 2020 Q4 | 23.2 Million USD | 45.15% |
| 2020 FY | - USD | 30.6% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | 99.39% |
| Addus HomeCare Corporation | 106.55 Million USD | 98.917% |
| AirSculpt Technologies, Inc. | 28.31 Million USD | 95.924% |
| Amedisys, Inc. | 216.91 Million USD | 99.468% |
| American Oncology Network, Inc. | -39.35 Million USD | 102.933% |
| Astrana Health, Inc. | 123.68 Million USD | 99.067% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | 97.398% |
| IMAC Holdings, Inc. | -5.94 Million USD | 119.405% |
| biote Corp. | 9.23 Million USD | 87.503% |
| Cryo-Cell International, Inc. | -10.41 Million USD | 111.078% |
| Cross Country Healthcare, Inc. | 129.33 Million USD | 99.108% |
| COMPASS Pathways plc | -123.8 Million USD | 100.932% |
| DocGo Inc. | 32.72 Million USD | 96.474% |
| The Ensign Group, Inc. | 353.23 Million USD | 99.673% |
| Healthcare Services Group, Inc. | 75.21 Million USD | 98.466% |
| Assure Holdings Corp. | -19.82 Million USD | 105.821% |
| The Joint Corp. | 9.14 Million USD | 87.377% |
| LifeStance Health Group, Inc. | -104.92 Million USD | 101.1% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | 107.419% |
| ModivCare Inc. | -26.75 Million USD | 104.314% |
| NewGenIvf Group Limited | 384.3 Thousand USD | -200.282% |
| Novo Integrated Sciences, Inc. | -5.84 Million USD | 119.73% |
| Option Care Health, Inc. | 376.79 Million USD | 99.694% |
| P3 Health Partners Inc. | -81.07 Million USD | 101.423% |
| P3 Health Partners Inc. | -81.07 Million USD | 101.423% |
| The Pennant Group, Inc. | 30.36 Million USD | 96.2% |
| Surgery Partners, Inc. | 446.1 Million USD | 99.741% |
| Syra Health Corp. Class A Common Stock | -2.83 Million USD | 140.693% |
| Talkspace, Inc. | -22.01 Million USD | 105.242% |
| Talkspace, Inc. | -22.01 Million USD | 105.242% |
| The Oncology Institute, Inc. | -70.45 Million USD | 101.638% |
| The Oncology Institute, Inc. | -70.45 Million USD | 101.638% |